ELAVL1 and neoplasm: These could include either inhibition of HuR protein translation by using siRNAs or suppression of its cytoplasmic translocation and inhibition of HuR mRNA target binding by using small molecules that act on the ligand receptors and on intracellular proteins critical for tumor growth.